Search results
Is Moderna Stock A Buy After Its Second-Ever Product Snags FDA Approval?
Investor's Business Daily· 5 days agoModerna will rival Pfizer and GSK, which launched their shots last year. Also, in June, Moderna and...
Biden admin seeks to delay releasing data on COVID vaccine reactions, report says
NBC Montana· 5 days agoThe Biden administration on Tuesday asked for a delay in releasing data on reactions to COVID-19 ...
3 No-Brainer Stocks to Buy for Under $100 Right Now
Motley Fool via Yahoo Finance· 3 days agoEven if that target proves overly optimistic, much of the negative impact of the patent cliff could be offset by these new products and indications. ...
3 No-Brainer Stocks to Buy for Under $100 Right Now
The Motley Fool via AOL· 3 days agoEven if that target proves overly optimistic, much of the negative impact of the patent cliff could be offset by these new products and indications. Pfizer built a massive ...
COVID is bouncing back this summer. Here’s what to know
Los Angeles Times· 9 hours agoSummer just started, but California’s not-too-surprising seasonal COVID bump is already going...
Feds try to delay release of non-public COVID vaccine safety data until at least 2026
Just the News· 6 days agoThe Biden administration is seeking to delay until at least 2026 the release of COVID-19 vaccine...
3 No-Brainer Stocks to Buy for Under $100 Right Now | The Motley Fool
The Motley Fool· 3 days agoHere's why they picked AstraZeneca (AZN 0.41%), Bristol Myers Squibb (BMY 2.17%), and Pfizer (PFE)....
Gateway - The Root
The Root· 7 days agoHealth experts in Mississippi and the federal level are urging residents in the state not to ingest ivermectin to treat COVID-19. In case you wanna know what ivermectin is, it is a drug designed ...
Unveiling the Medical Democide in the UK
Mercola· 4 days ago"Playing God: An Investigation into Medical Democide in the UK" is a documentary film that explores allegations of harmful medical practices and policies in the U.K. health care system. Directed ...
